Technology
Neurophet Signs MoU with InRAD to Establish Global Standards for Alzheimer's disease and Dementia Data
Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that it has signed a Memorandum of Understanding (MoU) with the International Registry for Alzheimer's Disease and Other Dementias Foundation (InRAD) to accelerate global standardization of Alzheimer's and dementia-related data.
About this update from Neurophet, Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"Neurophet's AI-based brain imaging analysis solutions to support global standardization of Alzheimer's and other dementia-related data","length":142,"tagName":"p"}]},{"val":[{"type":"text","content":"Enhancing dementia research by integrating AI imaging solutions with real-world data platforms","length":94,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":236,"olType":false},{"type":"text","content":"SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that it has signed a Memorandum of Understanding (MoU) with the International Registry for Alzheimer's Disease and Other Dementias Foundation (InRAD) to accelerate global standardization of Alzheimer's and dementia-related data.","length":457,"tagName":"p"},{"type":"image","alt":"Neurophet Signs MoU with InRAD to Establish Global Standards for Alzheimer’s disease and Dementia Data","displaySize":"","headline":null,"caption":"Neurophet Signs MoU with InRAD to Establish Global Standards for Alzheimer’s disease and Dementia Data","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":78,"url":"https://media.zenfs.com/en/prnewswire.com/6062f11cd1788283685a53410b4807ac"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/S21Oo9Wm591RBDmVTYo1pw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEzNztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/6062f11cd1788283685a53410b4807ac","width":400,"height":78}},"href":"https://mma.prnewswire.com/media/2761743/Neurophet_Signs_MoU_InRAD_Establish_Global_Standards_Alzheimer_s_disease_Dementia.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Through this agreement, Neurophet and InRAD aim to strengthen their collaboration to help establish globally harmonized standards for Alzheimer's disease and other dementias real-world data1. The partnership also seeks to enable the seamless integration of AI-based neuroimaging technologies into the broader real-world data landscape, removing one of the key practical barriers to evidence generation - namely, the lack of coordinated approaches - while acknowledging the wider adoption of these technologies in everyday clinical pra...